印度领先的冠状动脉支架制造商Translumina Therapeutics在阿联启动直接业务,扩大中东和北非地区的业务. Translumina Therapeutics, India's leading coronary stent manufacturer, launches direct operations in the UAE to expand MENA presence.
印度领先的冠状动脉支架制造商Translumina Therapeutics已在阿拉伯联合长国开展直接业务,以加强其在MENA地区的存在. Translumina Therapeutics, India's leading coronary stent manufacturer, has launched direct operations in the United Arab Emirates to enhance its presence in the MENA region. 该公司成立于2011年,与德国心脏中心合作开发了创新的冠状动脉干预装置和药物吸附剂技术。 Established in 2011, the company has developed innovative coronary intervention devices and drug-eluting stent technologies in collaboration with the German Heart Centre. 这一扩张与印度的“在印度创造,为世界创造”倡议是一致的,目的是增加全球获得医疗保健的机会。 This expansion aligns with India's "Make in India, Make for the World" initiative, aiming to boost global healthcare access.